Home > News > 93/Ablation strategies for persistent AF – A two-centre comparison of three technologies
Read Time: 2 mins

93/Ablation strategies for persistent AF – A two-centre comparison of three technologies

Published Online: October 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr93
Authors: ME Taylor (Presenting Author) - Freeman Hospital, Newcastle, UK; SH Chin - Liverpool Heart and Chest Hospital, Liverpool, UK; M Abbas - Freeman Hospital, Newcastle, UK; S Gupta - Freeman Hospital, Newcastle, UK; J Bourke - Freeman Hospital, Newcastle, UK; S Lord - Freeman Hospital, Newcastle, UK; R Martin - Freeman Hospital, Newcastle, UK; S Murray - Freeman Hospital, Newcastle, UK; E Shepherd - Freeman Hospital, Newcastle, UK; D Gupta - Liverpool Heart and Chest Hospital, Liverpool, UK; M Das - Freeman Hospital, Newcastle, UK
Quick Links:
Article Information

Introduction: For patients with persistent atrial fibrillation (PeAF), pulmonary vein isolation (PVI) remains the standard of care, although outcomes are often sub-optimal. AcQMap is a novel non-contact high resolution imaging and AF mapping system using dipole density mapping to identify areas triggering and maintaining AF.

Purpose: This two-centre retrospective observational study aimed to assess whether combined Cryoballoon PVI and AcQMap-guided
non-PVI ablation resulted in improved outcomes compared with Cryoballoon PVI alone or Carto-guided radiofrequency (RF) ablation in patients undergoing first time ablation for PeAF.

Methods: Data was collected from all patients who underwent first time ablation for PeAF at Freeman Hospital in Newcastle upon Tyne and Liverpool Heart and Chest Hospital between August 2016 and June 2018 with a minimum of 6 months of follow-up data. The use of combined AcQMap/Cryoballoon, Cryoballoon alone or Carto-guided PVI (with or without additional linear lesions) was as per operator preference. The primary endpoint was AF/atrial tachycardia (AT) recurrence after a 3-month blanking period.

Results: Two-hundred-and-seventeen patients (79% male, mean age 62 ± 10 years, 19.9% with severe LA dilatation, mean CHA2DS2-VASc score 1.48 ± 1.22) were included for analysis. Mean follow-up was 350 ± 122 days and was similar between the 3 groups, as were patient characteristics. Outcomes from the three strategies are shown in Table 1.


AF/AT recurrence following the initial procedure was similar for AcQMap/Cryoballoon and Carto-guided RF ablation (43% versus 46%). However, there were strong trends towards a higher recurrence rate with Cryoballoon alone (61%) when compared to these technologies, although these did not reach statistical significance (P=0.078 and P=0.058, respectively). In patients with arrhythmia recurrence following
AcQMap/Cryoballoon, this was most commonly AT (60%) rather than AF, whereas AF predominated following Cryoballoon only (94%) or Carto-guided ablation (94%). Overall success rates (after including redo procedures) were superior following an initial procedure with
AcQMap/Cryoballoon (73%) or Carto-guided RF (66%) compared to Cryoballoon alone (48%; p=0.017 and p=0.028, respectively).

Conclusion: Our two-centre real-world observational study showed similar first procedure outcomes with AcQMap/Cryoballoon and Carto-guided PVI ± substrate modification, with a strong trend towards inferior outcomes for Cryoballoon alone and significantly lower success rates for this technology after including redo procedures. Recurrence following AcQMap was most commonly AT, which may have contributed to improved outcomes being achieved after including redo procedures. Randomised controlled trials will be required to evaluate the efficacy of this costlier combined initial procedure against existing treatment modalities.

Article Information:

Further Resources

Share this Article
Related Content In Arrhythmia
43/Cardiac tamponade as a complication of transseptal puncture: associations and operatordependent variables during left atrial ablation at Barts Heart Centre
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; K Mahtani - St Bartholomew’s Hospital, London; C Butcher - St Bartholomew’s Hospital, London; N Ahluwalia - St Bartholomew’s Hospital, London; M Finlay - St Bartholomew’s Hospital, London; S Honarbakhsh - St Bartholomew’s Hospital, London; A Creta - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; V Sawhney - St Bartholomew’s Hospital, London; V Ezzat - St Bartholomew’s Hospital, London; MJ Earley - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; MD Lowe - St Bartholomew’s Hospital, London; PD Lambiase - St Bartholomew’s Hospital, London; F Khan - St Bartholomew’s Hospital, London; SY Ahsan - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; RJ Schilling - St Bartholomew’s Hospital, London; O Sega - St Bartholomew’s Hospital, London Read Time: 2 mins

European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr43

Introduction: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the incidence and predictors of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our centre from 2016-2020. Methods: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinised to adjudicate TSP culpability. Adjusted multivariate […]

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72